METHOD FOR INTENSIVE CARE OF MULTIPLE-ORGAN-FAILURE SYNDROME Russian patent published in 2012 - IPC A61M16/00 A61M1/34 A61B5/02 A61K31/403 A61K31/45 A61P7/08 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly anesthesiology and intensive care, and can be used for treating multiple-organ-failure syndrome in the patients who underwent cardiac surgeries. That is ensured by evaluation of the risk factors of developing multiple-organ-failure syndrome. Their absence enables standard intensive care. If within 12 hours after the cardiac surgery there are observed acute reduced cardiac output and reduced ejection fraction with the combined introduction of adrenaline and dobutamine appeared to be ineffective, differentiated interventional therapy of multiple-organ-failure syndrome is performed with using a calcium-sensitising agent taken among the cardiac support. The presence of haemodynamic criteria of acute lung injury combined with systemic inflammation response, prolonged renal replacement therapy in continuous veno-venous hemofiltration is performed. It is combined with a simultaneous complex of respiratory kinesiological rehabilitation with differentiated selection of a respiratory support method. On the forth day of artificial pulmonary ventilation, puncture-dilatation tracheostomy is performed.

EFFECT: method provides predicting a risk of developing multiple-organ-failure syndrome in a given category of patients at the early stage following the surgery.

2 ex